THE MEDICINES COMPANY AND WILMERHALE LAW FIRM REACH SETTLEMENT AGREEMENT
February 14, 2011
PARSIPPANY, NJ--(Marketwire - February 14, 2011) - The Medicines Company ( NASDAQ : MDCO ) announced today a settlement agreement with the law firm WilmerHale resolving all of The Medicines Company's potential claims against WilmerHale related to the principal U.S. patent covering the product Angiomax® (bivalirudin), U.S. Patent No. 5,196,404 (the '404 patent).
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from Settlement News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
